A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma

CompletedOBSERVATIONAL
Enrollment

335

Participants

Timeline

Start Date

April 9, 2021

Primary Completion Date

December 13, 2023

Study Completion Date

December 13, 2023

Conditions
Carcinoma, Hepatocellular
Interventions
DRUG

Lenvatinib

Oral capsules.

DRUG

Sorafenib

Oral tablets.

Trial Locations (44)

1090

Medizinische Universitat Wien (Medical University of Vienna), Vienna

1871

Liverpool Hospital, Liverpool

2050

Royal Prince Alfred Hospital, Camperdown

3100

Universitätsklinikum St. Pölten, Sankt Pölten

3168

Monash Health, Monash Medical Centre, Clayton

9020

Klinikum Klagenfurt Am Woerthersee, Klagenfurt

10467

Montefiore Medical Center, The Bronx

14004

C.H. Regional Reina Sofia - PPDS, Córdoba

15706

CHUS - H. Clinico U. de Santiago, Santiago de Compostela

28034

Hospital Universitario Ramon y Cajal, Madrid

39008

Hospital Universitario Marques de Valdecilla, Santander

40138

Azienda Ospedaliero Universitaria Di Bologna - Policlinico S Orsola Malpighi, Bologna

46026

Hospital Universitari i Politecnic La Fe de Valencia, Valencia

80147

Ospedale del Mare, Napoli

91105

California Liver Research Institute, Pasadena

428020

Budgetary Institution of the Chuvash Republic-The Republican Clinical Oncologic Dispensary-Cheboksar, Cheboksary

75390-0001

University of Texas Southwestern Medical Center, Dallas

Unknown

Universitätsklinikum Innsbruck, Innsbruck

Eisai Trial Site #3, Cologne

Eisai Trial Site #5, Mainz

Eisai Trial Site #2, Berlin

Eisai Trial Site #6, Munich

Eisai Trial Site #1, Ulm

Instituto Português de Oncologia Francisco Gentil Centro Regional de Oncologia de Coimbra EPE, Coimbra

Corporacio Sanitaria Parc Tauli, Sabadell

Hospital Universitario Virgen de La Arrixaca, El Palmar

Hospital Universitario de Getafe, Getafe

Hospital Regional Universitario de Malaga - Hospital General, Málaga

Hospital Universitario Virgen del Rocio - PPDS, Seville

Hospital Clinico Universitario Lozano Blesa, Zaragoza

Hospital Universitario Miguel Servet, Zaragoza

00133

Fondazione PTV Policlinico Tor Vergata, Rome

00152

Azienda Ospedaliera San Camillo Forlanini, Rome

00168

Fondazione Policlinico Universitario A Gemelli, Rome

09042

Azienda Ospedaliero Universitaria Di Cagliari, Monserrato Cagliari

2805-267

Hospital Garcia de Orta, Almada

1649-035

Centro Hospitalar Lisboa Norte, E.P.E. - Hospital de Santa Maria, Lisbon

5000-508

Centro Hospitalar Trás Os Montes E Alto Douro EPE, Vila Real

03010

Hospital General Universitario de Alicante, Alicante

141 86

Karolinska Universitetssjukhuset Huddinge, Stockholm

B15 2PR

University Hospitals Birmingham NHS Foundation Trust, Birmingham

EC1A 7BE

Barts Health NHS Trust - Charterhouse Square, London

NW3 2QG

Royal Free London NHS Foundation Trust, London

NG7 2UH

Nottingham University Hospitals NHS Trust, Nottingham

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY